Sarueda, Adela B.

HRN: 02-50-87  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2022
CEFTRIAXONE 1G (VIAL)
10/02/2022
10/08/2022
IV
2gm
Q24
Uti
Waiting Final Action 
10/04/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/04/2022
10/10/2022
IV
500mg
Q8
Amoebiasis With Severe Dehydration
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: